GSK (GSK plc) is a publicly traded company, meaning it is owned by a large number of shareholders rather than a single entity. Its shares are traded on the London Stock Exchange (LSE) and the New York Stock Exchange (NYSE). Ownership is broadly distributed among institutional investors, mutual funds, and individual shareholders. Institutional investors hold about 70% of the shares, mutual funds about 20%, and individual investors about 10%.
Key institutional shareholders include major investment management firms such as BlackRock Fund Advisors (around 3.1%), The Vanguard Group (around 2.7%), Dodge & Cox (around 2.4% to 3.8%), and others.
Thus, GSK does not have a single majority owner but is owned collectively by a diverse group of investors with no controlling private owner. The company's leadership is headed by CEO Emma Walmsley.
